The global Defibrillator market size is valued at 14.27 billion in 2022 and is predicted to reach 24.79 billion by the year 2031 at a 6.55% CAGR during the forecast period for 2023-2031.
Defibrillators are medical devices that are used to treat life-threatening cardiac arrhythmias. These devices deliver an electrical shock to the heart to restore its rhythm. Defibrillators are widely used in hospitals, emergency medical services, and other healthcare settings. The defibrillator market is expected to expand due to the increasing prevalence of cardiovascular conditions and the demand for advanced medical devices. The rising incidence of cardiovascular diseases, the aging population, and advancements in defibrillator technology drive the market.
However, there is a lack of awareness among the general public about defibrillators and their importance in treating sudden cardiac arrest. This can limit demand for the devices.
Recent Developments:
- In January 2019, BioTelemetry, Inc., a remote and wireless business specializing in health data, purchased Geneva Healthcare.
- In July 2020, Philips introduced a pre-hospital wireless monitoring solution for emergency medical response in the United States. The answer is an integrated, end-to-end system that expands first responders' pre-hospital spectrum of treatment by fusing cutting-edge hardware and cutting-edge software.
Competitive Landscape:
Some of the Defibrillator Market players are:
- Abbott
- AMI Italia
- Asahi Kasei Corporation
- Avive Solutions Inc.
- AXION Ltd.
- Bexen Cardio
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- BPL Medical Technologies
- Cardiac Science Corporation
- CU Medical Systems
- Element Science Inc.
- HeartHero Inc.
- Jeevtronics Pvt. Ltd.
- LivaNova PLC
- Mediana Co. Ltd.
- Medtronic plc
- Metrax GmbH – PRIMEDIC
- METsis Medikal
- MicroPort Scientific Corporation
- Mindray Medical International Ltd.
- MS Westfalia GmbH
- Nihon Kohden Corporation
- Philips Healthcare
- Progetti SRL – Medical Equipment Solutions
- Schiller AG
- Shenzhen Comen Medical Instruments Ltd.
- Jude Medical, Inc.
- Stryker Corporation
Market Segmentation:
The Defibrillator Market is segmented based on product and end-user. Based on product, the market is segmented into Implantable Defibrillators (Transvenous Implantable Cardioverter Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs), Cardiac Resynchronization Therapy- Defibrillator (CRT-D)), External Defibrillators (Manual External Defibrillator, Automated External Defibrillator (AEDs), and Wearable Cardioverter Defibrillator (WCDs)). By end-user, the market is segmented into hospitals, pre-hospitals, public access market, alternative care and home.
Based On Product, The Implantable Defibrillators Segment Is A Major Contributor In The Defibrillators Market
the implantable cardioverter-defibrillators (ICDs) segment is anticipated to dominate the defibrillator market terms of revenue during the forecast period. ICDs are implanted in the chest and continuously monitor the heart's rhythm. They can deliver a shock to the heart if an abnormal rhythm is detected and are used to treat patients at increased risk of sudden cardiac arrest. The demand for ICDs is driven by the rising incidence of cardiovascular diseases and the growing elderly population. As the population ages, the incidence of cardiovascular diseases increases, leading to a higher demand for ICDs. Additionally, advancements in ICD technology have led to more reliable and effective devices, further boosting their adoption.
The Hospital Segment Witnessed Growth At A Rapid Rate
The hospital segment is anticipated to dominate the defibrillator market in terms of end-users during the forecast period. Hospitals primarily use defibrillators, which are widely used in emergency departments, intensive care units, and cardiac catheterization labs. The demand for defibrillators in hospitals is driven by the increasing incidence of cardiovascular conditions and the growing elderly population. As the population ages, the incidence of cardiovascular diseases increases, leading to a higher demand for defibrillators in hospital settings. Additionally, advancements in defibrillator technology have led to more reliable and effective devices, further fueling their adoption in hospitals.
The North America Defibrillators Market Holds A Significant Revenue Share In The Region
The North American Defibrillators Market is expected to record the highest market share in revenue shortly. North America is presently the largest market for defibrillators in terms of revenue. The region has a well-developed healthcare infrastructure and advanced medical technology, contributing to the high adoption of defibrillators. The elevated prevalence of cardiovascular disorders in the region, especially in the United States, has also contributed to the market's growth. The United States is North America's largest market for defibrillators, followed by Canada. However, the market is expected to witness significant growth in the Asia-Pacific region during the forecast period, owing to the increasing incidence of cardiovascular diseases and the growing elderly population.
Defibrillator Market Report Scope:
|
Report Attribute |
Specifications |
|
Market size value in 2022 |
USD 14.27 Bn |
|
Revenue forecast in 2031 |
USD 24.79 Bn |
|
Growth rate CAGR |
CAGR of 6.55% from 2023 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Billion, and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Product And End-User |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
